Endeavors range from setting up a $1M center at IIT Kharagpur to start-up funds for new ventures to funding scholarships to new chapters and many more
Panelists will discuss our evolution towards individualized, personalized and targeted medicine and healthcare. Dr. Mendelsohn will share advances in our understanding and treatment of cancer emerging from our growing ability to sequence the genome of patients and their cancers. This was kicked off by the human genome project but has evolved into much more as we are beginning to identify and treat specific targets across cancers. Using the massive and exponentially growing amount of data generated by scientific advances in the last three decades is one of the biggest opportunities and challenges in medicine and Cerner is one of the leaders in this field. Mr. Flanigan will talk about the emergence and evolution of “big data” in healthcare and life sciences as we use the exabytes of new data to change the way we understand and treat disease. Nanotechnology is one of the most promising tools in personalized medicine. Dr. Tour will speak about the evolution of the nanotech journey and the promise of these tools. Dr. Ferrari will share the excitement around emerging customized nanotech tools that allow us to reach specific targets and deliver the promise of targeted or individualized therapies.